A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma
Clinical trial NCT02310412 · COMPLETED
Trial details
- NCT number
- NCT02310412
- Sponsor
- Cerus Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.